menu search

Plx pharma (plxp) q3 2022 earnings call transcript

PLx Pharma Inc. (NASDAQ:PLXP ) Q3 2022 Earnings Conference Call November 11, 2022 8:30 AM ET Company Participants Natasha Giordano - President, Chief ...

November 11, 2022, 11:13 am

Royalty pharma agrees to acquire royalty interest in olpasiran from arrowhead for $250 million and future milestones

Olpasiran is an siRNA therapeutic being developed by Amgen to reduce risk of cardiovascular disease Arr...

November 9, 2022, 1:49 pm

Here's the best growth stock to buy right now if you're worried about a recession

Macroeconomic pressures aren't much of an issue when all your customers are cardiovascular surgeons....

November 9, 2022, 5:26 am

cardiol therapeutics unveils new study data highlighting protective effects of cardiolrx in acute pericarditis

cardiol Therapeutics (TSX:CRDL, NASDAQ:CRDL) Inc revealed new study results highlighting the protective...

November 7, 2022, 9:18 am

cardiovascular systems, inc. (csii) q1 2023 earnings call transcript

cardiovascular Systems, Inc. (NASDAQ:CSII ) Q1 2023 Results Conference Call November 3, 2022 9:00 AM ET...

November 5, 2022, 1:58 pm

Biocardia to host q3 2022 financial results and corporate update conference call on november 9, 2022

SUNNYVALE, Calif., Nov. 02, 2022 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [NASDAQ:BCDA], a developer of cellular and cell-derived therapeutics for the tr...

November 2, 2022, 5:31 pm

Reviva pharmaceuticals to present at the h.c. wainwright 24th annual global investment conference

CUPERTINO, Calif., Sept. 07, 2022 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a clin...

September 7, 2022, 8:02 am

Bristol-myers, j&j and bayer presenting key study results at heart meeting

Investors should keep an eye on developments at the European Society of cardiology meeting, which is un...

August 29, 2022, 10:35 am

Biocardia to host q2 2022 financial results and corporate update conference call on august 10, 2022

SUNNYVALE, Calif., Aug. 04, 2022 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [NASDAQ:BCDA], a developer of cellular and cell-derived therapeutics for the tr...

August 4, 2022, 2:04 pm

cardiol therapeutics says first patient enrolled in acute myocarditis trial of its oral cannabinoid formulation cardiolrx

cardiol Therapeutics (TSX:CRDL, NASDAQ:CRDL) Inc. announced that the first patient has been enrolled in...

August 3, 2022, 1:54 pm

Alnylam pharmaceuticals is on track to hit a record high — here's why

Alnylam stock is on track to open at a record high Wednesday after its cardiomyopathy drug met every go...

August 3, 2022, 9:25 am

cardiol therapeutics to webcast virtual annual general meeting on june 28th at 4:30 p.m. edt

Oakville, Ontario--(Newsfile Corp. - June 27, 2022) - cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CR...

June 27, 2022, 10:07 am

Cytokinetics hopes to emulate vertex's market success, share price gains

If Cytokinetics Inc. ( CYTK , Financial) can come anywhere close to achieving its lofty ambition of becoming the Vertex Pharmaceuticals Inc. ( VRTX , ...

June 23, 2022, 4:05 pm

Medtronic: stable growth ahead

Medtronic has been a stable growth company for several decades. Leadership position in cardiovascular, ...

June 12, 2022, 8:45 am

Amgen (amgn) olpasiran lowers lipoprotein levels in phase ii

Amgen's (AMGN) olpasiran, a small interfering RNA molecule, is designed in such a way that it lowers the body's production of apolipoprotein(a), a key...

June 1, 2022, 10:32 am

Blue-chip stock could soon cool from recent rally

Blue-chip name Amgen, Inc.  (NASDAQ:AMGN) earlier reported its olpasiran therapy helped reduce cholesterol levels in patients with atherosclerotic ...

May 31, 2022, 3:07 pm

Medtronic plc (mdt) ceo geoff martha on q4 2022 results - earnings call transcript

Medtronic plc (NYSE:MDT ) Q4 2022 Earnings Conference Call May 26, 2022 8:00 AM ET Company Participants Ryan Weispfenning - Head of IR Geoff Martha - ...

May 26, 2022, 12:12 pm

cardiol therapeutics receives us fda authorization for phase ii study of cardiolrx for recurrent pericarditis

cardiol Therapeutics (TSX:CRDL, NASDAQ:CRDL) Inc announced that the US Food and Drug Administration has...

May 17, 2022, 10:07 am

Investors cheer revised, better than expected irhythm's fy22 outlook

iRhythm Technologies Inc (NASDAQ: IRTC) posted Q1 sales of $92.4 million, up 24.3% Y/Y, beating the consensus of $86.76 million. The developer of r...

May 6, 2022, 7:18 am

Lululemon's mirror home gym system partners with xponential fitness

Xponential Fitness Inc. XPOF, +1.68% announced Thursday that it has partnered with Lululemon Athletica Inc. LULU, -2.10% to create fitness programming...

April 21, 2022, 3:52 pm


Search within

Pages Search Results: